$ARM Leads While $AMGN and $CRWV Test New Bull Cycle Zones
Bullish momentum continues to build across biotech and AI infrastructure names, with several stocks either breaking out or testing key bull cycle zones.
From $ARM extending its powerful rally to $AMGN, $BMY, and $CRWV setting up for potential continuation moves, the focus remains on strong structure, improving buying pressure, and high-probability technical setups.
1. $Amgen(AMGN)$
$AMGN showing strength again inside its bull cycle.
This setup has led to a move toward $400 within 30–90 days about 63% of the time.
Structure remains bullish. If the bounce is going to happen, this is the spot.
Combined Signal System has now flipped long.
2. $ARM Holdings(ARM)$
This $ARM breakout has been impressive.
Up about 80% since the Combined Signal System flipped long and we swept that liquidity zone.
Within our frame, this is not a fresh buy area. It remains a hold, but now in clear premium territory.
3. $Bristol-Myers Squibb(BMY)$
$BMY already up over 4% since this post.
Cup and handle still looks strong, and the Monthly BX continues to show clear buying pressure.
I didn’t take this one because my fund has no extra capital right now, but this is exactly the type of structure and follow through we want to see.
4. $CoreWeave, Inc.(CRWV)$
$CRWV still compressing in this range, outlook unchanged.
New bull cycle is being tested. This is the zone where we often see 50% pushes over the next 60–120 days in this pattern.
😍 Been eyeing Tiger merch but short on Tiger Coins? Now's your chance.
🎁 We’ve selected 4 high-demand items across practial, lifestyle, and learning, now with a lower redemption threshold!
Hot Merch Returns · Up to 43% Off
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
her risk management, spoting good entries and staying up to date with the market always.